$ALNY Cashflow Statement | Understand Stock

$ALNY

$226.79 -$0.87 (0.38%) Close

$ALNY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
Amortization and interest accretion related to operating leases
Non-cash interest expense on liabilities related to the sale of future royalties and development funding
Stock-based compensation expense
Realized and unrealized loss on marketable equity securities
Loss related to convertible debt
Change in fair value of development derivative liability
Deferred income taxes
Other
Changes in operating assets and liabilities:
Accounts receivable, net
Inventory
Prepaid expenses and other assets
Accounts payable, accrued expenses and other liabilities
Operating lease liability
Deferred revenue
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment
Purchases of marketable securities
Sales and maturities of marketable securities
Proceeds from maturity of restricted investments
Purchases of restricted investments
Other investing activities
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from issuance of 0.00% Convertible Senior Notes due 2028, net
Repayment of term loan
Purchases of capped calls related to convertible debt
Proceeds from the sale of future royalties
Offering proceeds, net of costs
Proceeds from issuance of common stock to strategic partners, net of closing costs
Purchases of capped calls related to 0.00% Convertible Senior Notes due 2028
Repayment of 1.00% Convertible Senior Notes due 2027
Payment of issuance costs for revolving credit agreement
Proceeds from exercise of stock options and other types of equity, net
Proceeds from liabilities related to the sale of future royalties and development funding
Repayment of liabilities related to the sale of future royalties and development funding
(Repayment of) proceeds from development derivative liability, net
Repayment of term loan facility
Other financing activities
Net cash (used in) provided by financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of cash flows:
Cash paid for interest
Cash paid for income taxes
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities
Receivable and liability related to the sale of future royalties

Supplemental disclosure of noncash investing activities:
Capital expenditures included in accounts payable and accrued expenses

Comments